| Identifying true brain interaction from EEG data using the imaginary part of coherency G Nolte, O Bai, L Wheaton, Z Mari, S Vorbach, M Hallett Clinical neurophysiology 115 (10), 2292-2307, 2004 | 2132 | 2004 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 2018 | 2011 |
| Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease SP Yun, TI Kam, N Panicker, SM Kim, Y Oh, JS Park, SH Kwon, YJ Park, ... Nature medicine 24 (7), 931-938, 2018 | 1186 | 2018 |
| Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson … JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 2013 | 489 | 2013 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 357 | 2014 |
| Tourette syndrome deep brain stimulation: a review and updated recommendations LE Schrock, JW Mink, DW Woods, M Porta, D Servello, ... Movement disorders 30 (4), 448-471, 2015 | 284 | 2015 |
| Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry D Martinez-Ramirez, J Jimenez-Shahed, JF Leckman, M Porta, D Servello, ... JAMA neurology 75 (3), 353-359, 2018 | 269 | 2018 |
| National randomized controlled trial of virtual house calls for Parkinson disease CA Beck, DB Beran, KM Biglan, CM Boyd, ER Dorsey, PN Schmidt, ... Neurology 89 (11), 1152-1161, 2017 | 234 | 2017 |
| Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought P Rabins, BS Appleby, J Brandt, MR DeLong, LB Dunn, L Gabriëls, ... Archives of general psychiatry 66 (9), 931-937, 2009 | 231 | 2009 |
| Diffusion, spread, and migration of botulinum toxin J Ramirez‐Castaneda, J Jankovic, C Comella, K Dashtipour, ... Movement disorders 28 (13), 1775-1783, 2013 | 218 | 2013 |
| Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome A Lerner, A Bagic, JM Simmons, Z Mari, O Bonne, B Xu, D Kazuba, ... Brain 135 (6), 1926-1936, 2012 | 210 | 2012 |
| The past, present, and future of telemedicine for Parkinson's disease M Achey, JL Aldred, N Aljehani, BR Bloem, KM Biglan, P Chan, E Cubo, ... Movement disorders 29 (7), 871-883, 2014 | 207 | 2014 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 206 | 2015 |
| Asymmetric spatiotemporal patterns of event-related desynchronization preceding voluntary sequential finger movements: a high-resolution EEG study O Bai, Z Mari, S Vorbach, M Hallett Clinical neurophysiology 116 (5), 1213-1221, 2005 | 200 | 2005 |
| Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ... The Lancet Neurology 20 (3), 182-192, 2021 | 158 | 2021 |
| Continuous assessment of levodopa response in Parkinson's disease using wearable motion sensors CL Pulliam, DA Heldman, EB Brokaw, TO Mera, ZK Mari, MA Burack IEEE Transactions on Biomedical Engineering 65 (1), 159-164, 2017 | 151 | 2017 |
| Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ... JAMA neurology 78 (3), 312-320, 2021 | 150 | 2021 |
| Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls B Mollenhauer, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, ... Neurology 89 (19), 1959-1969, 2017 | 147 | 2017 |
| Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome A Lerner, A Bagic, EA Boudreau, T Hanakawa, F Pagan, Z Mari, ... Neurology 68 (23), 1979-1987, 2007 | 141 | 2007 |
| Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial B Bluett, DM Togasaki, D Mihaila, M Evatt, M Rezak, S Jain, ... Jama 326 (10), 926-939, 2021 | 137 | 2021 |
Greg PontoneUniversity of FloridaVerified email at ufl.edu
